For the latest updates and best practice for hepatitis B, see the update summary below.
Best Practice writes “Most people with hepatitis B infection are asymptomatic, although some present with complications such as cirrhosis, hepatocellular carcinoma, or liver failure. Serological markers are essential in making the diagnosis and evaluating disease activity, including for differentiation of acute and chronic infection, and for identifying chronic asymptomatic carriers. Therapy for acute infection is almost always supportive care alone. However, some patients with acute infection may develop liver failure, and these patients may require referral to liver transplant centre. Therapy for chronic infection includes nucleoside/nucleotide analogues, interferon-alfa, and pegylated interferon-alfa”. Click for more.